(Q67669416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

16 September 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

1 November 2022

author name string

H. H. Erlemeier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697569

1 November 2022

W. Kupper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697569

1 November 2022

W. Bleifeld

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697569

1 November 2022

language of work or name

English

0 references

publication date

1 August 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:0167527390900619?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

https://api.elsevier.com/content/article/PII:0167527390900619?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

International Journal of Cardiology

1 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

197-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist

16 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Approaches to sudden death from coronary heart disease

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

The natural history of primary first-degree atrioventricular heart block

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Haemodynamic and cardiac metabolic effects of the new β1 agonist prenalterol in patients with cardiac failure†

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

[Tolerance development during a 1-week course of dobutamine treatment].

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Tolerance to dobutamine after a 72 hour continuous infusion

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Antianginal effects of corwin, a new beta-adrenoceptor partial agonist

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Neurohumoral control mechanisms in congestive heart failure

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.

1 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Potential deleterious effects of inotropic agents in the therapy of chronic heart failure

1 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

Inotropic drugs and their mechanisms of action

1 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0167-5273(90)90061-9

1 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697569%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference